Source:http://linkedlifedata.com/resource/pubmed/id/19901969
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
Although Myc-interacting zinc-finger protein-1 (Miz-1) is known to be a poxvirus and zinc-finger (POZ) transcription factor required for Myc transcriptional repression, additional regulatory function of Miz-1 is less well understood. Using a yeast two-hybrid screen, we identified human alternate reading frame (ARF) protein as a novel interaction partner of Miz-1. The zinc-finger domain of Miz-1 is involved in its binding to ARF. In addition, we found that Miz-1 was able to interact with p53 through its DNA-binding domain, thus to diminish the binding of p53 to its target promoter and inhibit p53-mediated gene transcription. Interestingly, the Miz-1-regulated p53 transcriptional suppression does not require the presence of ARF or Mdm2. Importantly, ARF and p53 were found to competitively bind to Miz-1 in regulating p53-mediated transcription, and this conclusion was verified by both in vitro binding assay and competitive chromatin immunoprecipitation assay using a bona fide p53 endogenous Bax and Puma promoters. Thus, our study reveals that Miz-1 acts as a p53 suppressor by interfering with p53 DNA-binding ability, and ARF is able to counteract the suppression of Miz-1 on p53 by direct binding to Miz-1, suggesting that Miz-1 is a novel mediator in the ARF-p53 pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Kruppel-Like Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p14ARF,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/ZBTB17 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1476-5594
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
711-22
|
pubmed:meshHeading |
pubmed-meshheading:19901969-Gene Expression Regulation,
pubmed-meshheading:19901969-Humans,
pubmed-meshheading:19901969-Immunoblotting,
pubmed-meshheading:19901969-Immunoprecipitation,
pubmed-meshheading:19901969-Kruppel-Like Transcription Factors,
pubmed-meshheading:19901969-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:19901969-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19901969-Signal Transduction,
pubmed-meshheading:19901969-Transcription, Genetic,
pubmed-meshheading:19901969-Transcriptional Activation,
pubmed-meshheading:19901969-Tumor Suppressor Protein p14ARF,
pubmed-meshheading:19901969-Tumor Suppressor Protein p53,
pubmed-meshheading:19901969-Two-Hybrid System Techniques
|
pubmed:year |
2010
|
pubmed:articleTitle |
ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
|
pubmed:affiliation |
Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|